Recent studies demonstrate that endocannabinoids act as retrograde messengers, inhibiting synaptic transmission in several brain regions including the cerebellum. In cerebellar Purkinje cells, elevation of postsynaptic calcium evokes release of endocannabinoids which diffuse to presynaptic targets, activating G-protein linked cannabinoid receptors, and suppressing synaptic transmission for tens of seconds. Recent work highlights the widespread importance of endocannabinoid signaling, yet several fundamental issues remain unanswered. We will investigate basic aspects of endocannabinoid signaling, using whole cell recording and calcium imaging techniques in the cerebellar slice preparation. The proposed experiments will (a) investigate mechanisms of endocannabinoid release from Purkinje cell dendrites, (b) characterize physiological and stimulus conditions under which release occurs, and (c) determine the physiological role of retrograde inhibition. These studies will clarify the function of endogenous cannabinoid signaling in the cerebellum and will contribute to therapeutic approaches to neurological disorders that involve disruptions of the cannabinoid system, including Huntington's and Parkinson's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32NS046842-02
Application #
6790659
Study Section
Special Emphasis Panel (ZRG1-F03B (20))
Program Officer
Talley, Edmund M
Project Start
2003-08-01
Project End
2005-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
2
Fiscal Year
2004
Total Cost
$48,928
Indirect Cost
Name
Harvard University
Department
Biology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115